About the Journal
The Journal of Atherosclerosis and Dyslipidemias (JAD, Ateroskleroz i dislipidemii)
An official Journal of the Russian National Atherosclerosis Society (RNAS)
Mass media registration certificate ФС 77-39935 (20.05.2010)
ISSN 2409-2355 (Online), ISSN 2219-8202 (Print).
Subscription index 90913
DOI: 10.34687/2219-8202.JAD
The journal is peer-reviewed, with multistage editing. The Journal is included in the List of scientific journals and publications of the Higher Attestation Commission (VAK) of Russia for publishing of major scientific results of research addressing PhD or other recognized medical degree theses defense.
Russian Science Citation Index 2-year Impact Factor 2019: 1,270
The circulation is 5000 of copies, 4 issues per year.
The Journal is free distributed by mail all over the Russian Federation, including medical universities and big medical centers.
The language of publications is Russian, with abstracts of all articles presented in English as well.
AIM AND SCOPE
The aims and scope of the title are in accordance to the aims and scope of RNAS: to make available for the wide range of researchers and practical clinicians the latest information about etiology, pathogenesis, diagnostics and treatment of atherosclerosis and dyslipidaemias.
The journal contains research and review articles concerning latest findings in atherosclerosis and dyslipidaemias field, including research of lipid metabolism, markers of inflammation and thrombosis, vascular pathology, risk factors and predicting cardiovascular diseases, prevention of atherosclerosis and its complications.
Instructions for Authors should be used to prepare the manuscripts. All manuscripts are to be submitted via the internet using submission form.
All submitted materials are reviewed and discussed at the Editorial Board meeting.
All inquiries regarding journal policy should be directed to the Editorial Office: JAD_cardio@mail.ru.
Last updated: 11.2021